Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 17, 2026
Sale
Shares
8,282
Price
$65.07
Total Value
$538.92K
Shares Held After
117,066
% of Holdings
6.6%

Canopy Growth Corp (CGC)

Stewart Thomas Carlton — Chief Financial Officer and Chief Accounting Officer
Sep 17, 2026
Sale
Shares
25,755
Price
$0.93
Total Value
$23.95K
Shares Held After
588,412
% of Holdings
4.2%
Sep 17, 2026
Sale
Shares
400,000
Price
$30.33
Total Value
$12.13M
Shares Held After
230,303
% of Holdings
63.5%
Sep 17, 2026
Sale
Shares
180,000
Price
$0.01
Total Value
$1.80K
Shares Held After
23,615,742
% of Holdings
0.8%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Sep 16, 2026
Sale
Shares
1,654
Price
$153.24
Total Value
$253.46K
Shares Held After
0
% of Holdings
100.0%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Sep 16, 2026
Sale
Shares
989
Price
$152.36
Total Value
$150.69K
Shares Held After
1,654
% of Holdings
37.4%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Sep 16, 2026
Sale
Shares
1,659
Price
$151.16
Total Value
$250.77K
Shares Held After
2,643
% of Holdings
38.6%

REVVITY, INC. (RVTY)

Vohra Tajinder S — Senior Vice President, Global Operations
Sep 16, 2026
Sale
Shares
7,330
Price
$140.88
Total Value
$1.03M
Shares Held After
6,635
% of Holdings
52.5%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Sep 16, 2026
Sale
Shares
3,674
Price
$25.00
Total Value
$91.85K
Shares Held After
112,508
% of Holdings
3.2%

Tempus AI, Inc. (TEM)

Fukushima Ryan — CEO, Data
Sep 16, 2026
Sale
Shares
700
Price
$70.00
Total Value
$49.00K
Shares Held After
15,874
% of Holdings
4.2%

Adaptive Biotechnologies Corp (ADPT)

LO FRANCIS — Chief People Officer
Sep 16, 2026
Sale
Shares
7,869
Price
$28.57
Total Value
$224.82K
Shares Held After
220,867
% of Holdings
3.4%

Adaptive Biotechnologies Corp (ADPT)

LO FRANCIS — Chief People Officer
Sep 16, 2026
Sale
Shares
107,537
Price
$28.02
Total Value
$3.01M
Shares Held After
228,736
% of Holdings
32.0%
Sep 16, 2026
Sale
Shares
296
Price
$100.82
Total Value
$29.84K
Shares Held After
3,946
% of Holdings
7.0%
Sep 16, 2026
Sale
Shares
1,285
Price
$1.91
Total Value
$2.45K
Shares Held After
5,616
% of Holdings
18.6%
Sep 16, 2026
Sale
Shares
32,607
Price
$1.91
Total Value
$62.28K
Shares Held After
142,463
% of Holdings
18.6%

Revolution Medicines, Inc. (RVMD)

Mancini Anthony — Chief Global Commercialization Officer
Sep 16, 2026
Sale
Shares
1,747
Price
$199.30
Total Value
$348.18K
Shares Held After
42,116
% of Holdings
4.0%

Revolution Medicines, Inc. (RVMD)

Mancini Anthony — Chief Global Commercialization Officer
Sep 16, 2026
Sale
Shares
27
Price
$195.05
Total Value
$5.27K
Shares Held After
43,863
% of Holdings
0.1%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 16, 2026
Sale
Shares
5,484
Price
$199.30
Total Value
$1.09M
Shares Held After
286,307
% of Holdings
1.9%

Revolution Medicines, Inc. (RVMD)

Sandler Alan B. — Chief Development Officer
Sep 16, 2026
Sale
Shares
336
Price
$199.30
Total Value
$66.97K
Shares Held After
52,868
% of Holdings
0.6%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 16, 2026
Sale
Shares
85
Price
$195.01
Total Value
$16.58K
Shares Held After
291,791
% of Holdings
0.0%

Revolution Medicines, Inc. (RVMD)

Sandler Alan B. — Chief Development Officer
Sep 16, 2026
Sale
Shares
5
Price
$194.96
Total Value
$974.79
Shares Held After
53,204
% of Holdings
0.0%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Sep 16, 2026
Sale
Shares
4,891
Price
$199.30
Total Value
$974.79K
Shares Held After
149,680
% of Holdings
3.2%

Revolution Medicines, Inc. (RVMD)

Horn Margaret A — Chief Operating Officer
Sep 16, 2026
Sale
Shares
76
Price
$195.01
Total Value
$14.82K
Shares Held After
154,571
% of Holdings
0.0%

Revolution Medicines, Inc. (RVMD)

Cislini Jeff — SVP&General Counsel
Sep 16, 2026
Sale
Shares
3,314
Price
$199.30
Total Value
$660.49K
Shares Held After
52,541
% of Holdings
5.9%

Revolution Medicines, Inc. (RVMD)

Cislini Jeff — SVP&General Counsel
Sep 16, 2026
Sale
Shares
52
Price
$195.01
Total Value
$10.14K
Shares Held After
55,855
% of Holdings
0.1%
Sep 16, 2026
Sale
Shares
13,775
Price
$199.30
Total Value
$2.75M
Shares Held After
253,342
% of Holdings
5.2%

Revolution Medicines, Inc. (RVMD)

Anders Jack — Chief Financial Officer
Sep 16, 2026
Sale
Shares
3,992
Price
$199.30
Total Value
$795.62K
Shares Held After
119,216
% of Holdings
3.2%
Sep 16, 2026
Sale
Shares
213
Price
$195.01
Total Value
$41.54K
Shares Held After
267,117
% of Holdings
0.1%

Revolution Medicines, Inc. (RVMD)

Anders Jack — Chief Financial Officer
Sep 16, 2026
Sale
Shares
61
Price
$195.00
Total Value
$11.89K
Shares Held After
123,208
% of Holdings
0.0%
Sep 16, 2026
Sale
Shares
7,006
Price
$67.35
Total Value
$471.85K
Shares Held After
1,306,594
% of Holdings
0.5%
Sep 16, 2026
Sale
Shares
2,994
Price
$66.58
Total Value
$199.34K
Shares Held After
1,313,600
% of Holdings
0.2%

Harmony Biosciences Holdings, Inc. (HRMY)

Budur Kumar — CHIEF MEDICAL OFFICER
Sep 16, 2026
Sale
Shares
1,800
Price
$43.01
Total Value
$77.43K
Shares Held After
13,115
% of Holdings
12.1%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
4
Price
$172.00
Total Value
$688.00
Shares Held After
72,433
% of Holdings
0.0%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
234
Price
$170.95
Total Value
$40.00K
Shares Held After
72,437
% of Holdings
0.3%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
120
Price
$168.38
Total Value
$20.21K
Shares Held After
72,671
% of Holdings
0.2%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
460
Price
$167.32
Total Value
$76.97K
Shares Held After
72,791
% of Holdings
0.6%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
191
Price
$166.20
Total Value
$31.74K
Shares Held After
73,251
% of Holdings
0.3%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
345
Price
$164.60
Total Value
$56.79K
Shares Held After
73,442
% of Holdings
0.5%

GLAUKOS Corp (GKOS)

Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
103
Price
$163.20
Total Value
$16.81K
Shares Held After
73,787
% of Holdings
0.1%

TELA Bio, Inc. (TELA)

Capper Joseph H — Director
Sep 16, 2026
Purchase
Shares
50,000
Price
$1.17
Total Value
$58.27K
Shares Held After
154,827
% of Holdings
32.3%

Avalo Therapeutics, Inc. (AVTX)

Sullivan Christopher Ryan — Chief Financial Officer
Sep 16, 2026
Sale
Shares
12,394
Price
$16.33
Total Value
$202.44K
Shares Held After
39,900
% of Holdings
23.7%
Sep 16, 2026
Sale
Shares
16,509
Price
$11.67
Total Value
$192.66K
Shares Held After
137,044
% of Holdings
10.8%

CRESCENT BIOPHARMA, INC. (CBIO)

Bispham Barbara Harlin — General Counsel and Corporate Secretary.
Sep 16, 2026
Sale
Shares
620
Price
$17.90
Total Value
$11.10K
Shares Held After
18,710
% of Holdings
3.2%

CRESCENT BIOPHARMA, INC. (CBIO)

Scalzo Richard William — Chief Financial Officer
Sep 16, 2026
Sale
Shares
568
Price
$17.90
Total Value
$10.17K
Shares Held After
19,730
% of Holdings
2.8%

CRESCENT BIOPHARMA, INC. (CBIO)

Im Ellie Eunkyung — Chief Medical Officer
Sep 16, 2026
Sale
Shares
623
Price
$17.90
Total Value
$11.15K
Shares Held After
21,446
% of Holdings
2.8%

CRESCENT BIOPHARMA, INC. (CBIO)

Pinkas Jan — Chief Scientific Officer
Sep 16, 2026
Sale
Shares
658
Price
$17.90
Total Value
$11.78K
Shares Held After
21,581
% of Holdings
3.0%
Sep 16, 2026
Sale
Shares
1,610
Price
$17.90
Total Value
$28.82K
Shares Held After
279,602
% of Holdings
0.6%

CRESCENT BIOPHARMA, INC. (CBIO)

McNeill Jonathan — President and COO
Sep 16, 2026
Sale
Shares
731
Price
$17.90
Total Value
$13.08K
Shares Held After
138,427
% of Holdings
0.5%

CRESCENT BIOPHARMA, INC. (CBIO)

Lynch Ryan — Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Sep 16, 2026
Sale
Shares
240
Price
$17.90
Total Value
$4.30K
Shares Held After
13,631
% of Holdings
1.7%

ICON PLC (ICLR)

CLIMAX JOHN DR — Director
Sep 16, 2026
Sale
Shares
5,005
Price
$175.00
Total Value
$875.88K
Shares Held After
2,087
% of Holdings
70.6%
Version: v26.9.1